Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality

Cited by papers we hold 15

• STAT3 and its targeting inhibitors in osteosarcoma · 2020
  No notice
• JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation · 2019
  No notice
• “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway · 2018
  No notice
• A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis · 2017
  No notice
• Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis · 2017
  Corrected
• The many faces of Pluripotency: in vitro adaptations of a continuum of in vivo states · 2017
  No notice
• Cancer Stem Cell Hierarchy in Glioblastoma Multiforme · 2016
  No notice
• Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6 · 2016
  No notice
• STATs: An Old Story, Yet Mesmerizing. · 2015
  No notice
• A Cohesin-Independent Role for NIPBL at Promoters Provides Insights in CdLS · 2014
  No notice
• STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits · 2013
  No notice
• Embryonic Stem Cell Markers · 2012
  No notice
• Thrombospondin-1: Multiple Paths to Inflammation · 2011
  No notice
• Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-β1 · 2011
  No notice
• Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas · 2008
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.